share_log

TC BioPharm Shares Are Trading Higher After the Company Announced It Dosed 5 New Patients in Its ACHIEVE Phase 2b Trial.

TC BioPharm Shares Are Trading Higher After the Company Announced It Dosed 5 New Patients in Its ACHIEVE Phase 2b Trial.

TC BioPharm股价上涨,因为该公司宣布其ACHIEVE第20亿期试验给5名新患者注射了试药。
Benzinga ·  09/03 10:08

TC BioPharm Shares Are Trading Higher After the Company Announced It Dosed 5 New Patients in Its ACHIEVE Phase 2b Trial.

TC BioPharm股价上涨,因为该公司宣布其ACHIEVE第20亿期试验给5名新患者注射了试药。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发